Basics Vivos Therapeutics, Inc. IPO Date: July 7, 2020 Sector: Healthcare Industry: Medical Devices Market Cap: $13.37M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 5.13% Avg Daily Range (30 D): $0.10 | 3.78% Avg Daily Range (90 D): $0.13 | 4.04% Institutional Daily Volume Avg Daily Volume: .89M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 296 Avg Trade Size (Sh.) (30 D): 241 Avg Trade Size (Sh.) (90 D): 208 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $.81M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $.84M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $1.03M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 15.45K         News Jun 27, 2024 @ 11:30 AM Vivos Therapeutics Announces Positive Results From... Source: Vivos Therapeutics, Inc Jun 12, 2024 @ 11:30 AM Vivos Therapeutics Closes $7.5 Million At-The-Mark... Source: Vivos Therapeutics, Inc May 14, 2024 @ 11:30 AM Vivos Therapeutics Schedules Release of First Quar... Source: Vivos Therapeutics, Inc Apr 9, 2024 @ 11:30 AM Vivos Therapeutics’ Flagship CARE Oral Medi... Source: Vivos Therapeutics, Inc Apr 1, 2024 @ 12:08 PM Why Doma Holdings Shares Are Trading Higher By Aro... Source: Avi Kapoor Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.21 $-.45 Diluted EPS $-1.21 $-.45 Revenue $ 14.63M $ 3.02M $ Gross Profit $ 8.59M $ 1.51M $ Net Income / Loss $ -11.24M $ -3.86M $ Operating Income / Loss $ -11.31M $ -3.92M $ Cost of Revenue $ 6.04M $ 1.51M $ Net Cash Flow $ 4.62M $ M $ PE Ratio     Splits Oct 27, 2023:   1:25